ACQUIRED · 2018
Who Acquired Xstrahl?
Risk Capital Partners · $25.0M· 9.6× EBITDA
The acquisition
Xstrahl was acquired by Risk Capital Partners in 2018 for $25.0M. The deal was priced at 9.6× EBITDA / 1.90× revenue.
Xstrahl at time of acquisition
Revenue
$13.5M
EBITDA
$2.6M
Deal value
$25.0M
EV / EBITDA
9.6×
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press releases and press reporting. Full deal page.
Citation: ExitValue.ai. (2018). Xstrahl acquired by Risk Capital Partners. https://exitvalue.ai/acquired/xstrahl